Fieldpoint Private Securities’s BioNTech BNTX Stock Holding History

Fieldpoint Private Securities’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$7K	Sell	45 -15	-25%	-$2.29K	﹤0.01%	805
2022 Q1	$10K	Buy	60 +15	+33%	+$2.52K	﹤0.01%	1067
2021 Q4	$12K	Buy	45 +20	+80%	+$5.48K	﹤0.01%	1022
2021 Q3	$7K	Hold	25	–	–	﹤0.01%	1150
2021 Q2	$10K	Buy	25 +10	+67%	+$1.89K	﹤0.01%	1006
2021 Q1	$2K	Buy	15 +10	+200%	+$1.06K	﹤0.01%	1358
2020 Q4	$0	Buy	+5	New	+$491	﹤0.01%	1492

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Fieldpoint Private Securities's BNTX Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its BioNTech (BNTX) stake by 25% in Q2 2022, selling an estimated $2.29K and leaving 45 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #805.

Fieldpoint Private Securities first reported a position in BNTX in Q4 2020 and has held it in 7 quarters since. The position peaked at $12K in Q4 2021. 292 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

Fieldpoint Private Securities held 45 shares of BioNTech worth $7K as of Q2 2022.
Fieldpoint Private Securities sold 15 BioNTech shares in Q2 2022, an estimated $2.29K.
BioNTech made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #805 holding.
Fieldpoint Private Securities first reported a position in BioNTech in Q4 2020 and has held it in 7 quarters since.
Fieldpoint Private Securities's BioNTech position peaked at $12K in Q4 2021.
292 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.